Preventative Angioplasty Reduces Mortality Risk after Heart Attack
|
By HospiMedica International staff writers Posted on 10 Sep 2019 |
Complete multivessel revascularization following a ST-segment elevation myocardial infarction (STEMI) reduces the risk of cardiovascular death, according to a new study.
Researchers at McMaster University (Hamilton, ON, Canada), Instituto Dante Pazzanese de Cardiologia (São Paulo, Brazil), and an additional 128 hospitals in 31 countries randomly assigned 4,131 patients with STEMI and multivessel coronary artery disease (CAD) who underwent successful culprit-lesion PCI to a strategy of either complete revascularization with percutaneous coronary intervention (PCI) of all angiographically significant nonculprit lesions (2,106 patients), or no further revascularization (2,025 controls). The main outcome was the composite of cardiovascular death or MI.
The results at median three year follow-up showed that 7.8% of patients in the total revascularization group suffered the main outcome, compared with 10.5% in the control, culprit-lesion only PCI group. When taking into account ischemia-driven revascularization, the difference was even greater, at 8.9% in the complete revascularization group, compared to 16.7% in the culprit-lesion-only controls. The benefit of complete revascularization was consistently observed, regardless of the intended timing of nonculprit lesion PCI. The study was published on September 1, 2019, in the New England Journal of Medicine (NEJM).
“Although it had been known that opening of the single blocked artery that caused the heart attack with stents was beneficial, it was unclear whether additional stents to clear the other clogged arteries further prevented death or heart attack,” said lead author Shamir Mehta, MD, of McMaster University. “In most cases, doctors would just treat the additional blockages with medication alone. This study clearly showed that there is long-term benefit in preventing serious heart-related events by clearing all of the arteries. There was also no major downside to the additional procedures.”
PCI (formerly known as angioplasty with stent) is a non-surgical procedure that accesses the coronary vessels through the femoral or radial artery using a catheter and fluoroscopy to access atherosclerotic plaque obstructions. An interventional cardiologist can then perform an angioplasty, using a balloon catheter to inflate to relieve the narrowing; in many case, a stent is deployed to keep the blood vessel open. Various other procedures can also be performed.
Related Links:
McMaster University
Instituto Dante Pazzanese de Cardiologia
Researchers at McMaster University (Hamilton, ON, Canada), Instituto Dante Pazzanese de Cardiologia (São Paulo, Brazil), and an additional 128 hospitals in 31 countries randomly assigned 4,131 patients with STEMI and multivessel coronary artery disease (CAD) who underwent successful culprit-lesion PCI to a strategy of either complete revascularization with percutaneous coronary intervention (PCI) of all angiographically significant nonculprit lesions (2,106 patients), or no further revascularization (2,025 controls). The main outcome was the composite of cardiovascular death or MI.
The results at median three year follow-up showed that 7.8% of patients in the total revascularization group suffered the main outcome, compared with 10.5% in the control, culprit-lesion only PCI group. When taking into account ischemia-driven revascularization, the difference was even greater, at 8.9% in the complete revascularization group, compared to 16.7% in the culprit-lesion-only controls. The benefit of complete revascularization was consistently observed, regardless of the intended timing of nonculprit lesion PCI. The study was published on September 1, 2019, in the New England Journal of Medicine (NEJM).
“Although it had been known that opening of the single blocked artery that caused the heart attack with stents was beneficial, it was unclear whether additional stents to clear the other clogged arteries further prevented death or heart attack,” said lead author Shamir Mehta, MD, of McMaster University. “In most cases, doctors would just treat the additional blockages with medication alone. This study clearly showed that there is long-term benefit in preventing serious heart-related events by clearing all of the arteries. There was also no major downside to the additional procedures.”
PCI (formerly known as angioplasty with stent) is a non-surgical procedure that accesses the coronary vessels through the femoral or radial artery using a catheter and fluoroscopy to access atherosclerotic plaque obstructions. An interventional cardiologist can then perform an angioplasty, using a balloon catheter to inflate to relieve the narrowing; in many case, a stent is deployed to keep the blood vessel open. Various other procedures can also be performed.
Related Links:
McMaster University
Instituto Dante Pazzanese de Cardiologia
Latest Surgical Techniques News
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
- Skull Implant Design Could Shape Surgical Outcomes
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







